Transgene Biotek Ltd.
Snapshot View

View in App

Prices View details >>

3.10 -0.06 ▼-1.9%

27 September 2022, 10:47:00 AM
Volume: 1,246

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.transgenebiotek.com
Market Cap 23.94 Cr.
Enterprise Value(EV) 36.03 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -1.21 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 48.77 Trailing Twelve Months Ending 2022-06
Book Value / Share 1.38 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.30 Calculated using Price: 3.17
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 7.58 Cr. 75,770,000 Shares
FaceValue 10
Company Profile
Transgene Biotek Ltd (TBL) was set up in 1991, and was probably the first true Biotechnology Company in India. It is listed on the Indian Stock Exchanges and is involved in the development of several cutting edge technologies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.90%
1 Week
-4.32%
1 Month
-6.06%
3 Month
-10.40%
6 Month
-20.72%
1 Year
-9.88%
2 Year
-29.55%
5 Year
+19.23%
10 Year
-71.45%

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -0.64 -50.54 -9.63 -11.78 -17.03 -11.57 -18.31 -28.73 -38.00
Return on Capital Employed (%) -0.54 -47.36 -8.84 -10.85 -14.68 -6.74 -14.83 -22.10 -26.55
Return on Assets (%) -0.55 -36.70 -5.45 -6.56 -7.77 -3.35 -4.84 -6.39 -6.45

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 322 206 191 174 59 52 44 33 22 17
Non Curr. Liab. 12 127 127 127 127 120 120 120 120 121
Curr. Liab. 35 26 25 11 12 14 13 14 14 9
Minority Int.
Equity & Liab. 369 358 344 313 198 187 177 167 157 147
Non Curr. Assets 348 338 326 310 197 186 176 166 156 146
Curr. Assets 21 20 18 3 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 369 358 344 313 198 187 177 167 157 147

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 15 1 0 0 0 0 0 0 0
Other Income 0 1 0 0 1 7 2 0 0 0
Total Income 15 2 0 0 1 7 2 0 0 0
Total Expenditure -16 -3 -2 -1 -3 -2 -1 -1 -1 -1
PBIDT -1 -1 -2 -1 -2 5 1 -1 0 0
Interest 0 0 0 0 -1 0 0 0 0
Depreciation -1 -17 -17 -21 -18 -10 -10 -10 -10 -9
Taxation -1
Exceptional Items -115
PAT -2 -133 -19 -22 -20 -6 -9 -11 -10 -9
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -2 -133 -19 -22 -20 -6 -9 -11 -10 -9
Adjusted EPS 0 -18 -3 -3 -3 -1 -1 -1 -1 -1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 25 13 -2 4 6 0 -1 -2 0 0
Cash Fr. Inv. -144 -15 1 -5 -6 3 2 0
Cash Fr. Finan. 83 2 1 1 -2 0
Net Change -36 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64
Public 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 13 Sep 2022
Newspaper Advertisement - Notice Of 32Nd Annual General Meeting Remote E- Voting Information Record Date And Book Closure Etc.
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find attached herewith copies of newspaper advertisement published in Business Standard (English) and Nava Telangana (Telugu) both newspapers having electronic editions on 12th September 2022 regarding Notice for the 32nd Annual General Meeting of the Company including record date book closer
Fri, 02 Sep 2022
Reg. 34 (1) Annual Report.
Pursuant to Regulation 34(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Annual Report for the year ended 31st March 2022 containing Notice of the 32nd Annual General Meeting scheduled to be held on Friday 30th September 2022 at 10.00 a.m. through Video Conference / Other Audio Visual Means (OAVM) in accordance with various circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.The voting period begins on Tuesday September 27 2022 at 09.00 hrs and ends on Thursday September 29 2022 at 17.00 hrs.Kindly note that the soft copies of Annual Report containing Notice of 32nd Annual General Meeting is being uploaded on the website of Company at www.transgenebiotek.com
Sat, 13 Aug 2022
Board Meeting Outcome for Outcome Of Board Meeting.
This has reference to our letter dated 20th July 2022.

At the meeting of the Board of Directors of the company held on 13th August 2022 the following
decisions were taken:

1) It was decided to hold the 32nd Annual General Meting on Friday the 30th September 2022 at
IST through Video-Conferencing (VC") / Other Audio-Visual Means ("OAVM") at 10.00
A.M. (IST).

2) The Register of Members and Share Transfer Books of the Company will remain closed from
Monday the 26th September 2022 to Thursday the 29th September 2022 (both days inclusive).

3) The Board approved the Unaudited Financial Results (Standalone & Consolidated) along with
Limited Review Report of the Company for the quarter ended on 30th June. 2022.

4) The Board considered and approved appointment of M/s. Geeta Serwani & Associates
Practicing Company Secretaries as the Secretarial Auditor of the Company for the financial
year 2021-2022.

The meeting commenced at 11.00 A.M and concluded at 12.00 P.M.

Technical Scans View Details >>

Mon, 26 Sep 2022
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
CCI Oversold Zone CCI Oversold Zone
Fri, 23 Sep 2022
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 896.40 -0.1%
Divi's Laboratories Ltd. 97,676.51 3,640.10 -0.8%
Cipla Ltd. 85,998.13 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. 51,200.03 1,511.00 -0.2%
Max Healthcare Institute Ltd. 40,653.72 410.30 -1.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-06 34.59 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 410.30 -1.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-06 4.00 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 410.30 -1.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 410.30 -1.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 410.30 -1.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 410.30 -1.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 410.30 -1.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 896.40 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,640.10 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,081.55 +1.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,150.00 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,246.15 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,511.00 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 410.30 -1.7%

FAQ's On Transgene Biotek Ltd.

What is Transgene Biotek share price?
Can I buy Transgene Biotek shares now?
What is the Market Cap of Transgene Biotek?
What are the key metrics to analyse Transgene Biotek?
What is the 52 Week High and Low of Transgene Biotek?
What is the trend of Transgene Biotek share price?